More than 30 years ago, Mark Atkinson, PhD ’88, was given three research questions that he would spend his career trying to solve.
What is the cause of Type 1 diabetes?
Who may develop the disease — and why?
Can we find a cure?
“Mike started working with us when he was 18, and now he’s leading the division... He is the next generation.”
Desmond Schatz, MD
UF Diabetes Institute
Dr. Haller is partnering with researchers throughout the United States, leading a first-of-its-kind clinical trial supported by the Helmsely Trust, Sanofi and the NIG, using FDA-approved combination of drug therapy.
Find out how researchers are answering the “What ifs” of diabetes
Todd Brusko, PhD
Jing Chen, MD, PhD
“We think this type of dysfunction contributes to the development of Type 1 diabetes.”
Laura Jacobsen, MD
“What this could tell us is whether we need better screening tools and better support for patients”
Kenneth Cusi, MD
"My primary aim was to develop a comprehensive state-of-the-art endocrine and diabetes program."